NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
1.580
-0.060 (-3.66%)
Dec 5, 2025, 4:00 PM EST - Market closed
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $12.87 million as of December 5, 2025. Its market cap has decreased by -47.50% in one year.
Market Cap
12.87M
Enterprise Value
15.12M
1-Year Change
-47.50%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has decreased from $19.59M to $12.87M, a decrease of -34.32%. That is a compound annual growth rate of -10.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 12.87M | -61.63% |
| Dec 31, 2024 | 33.53M | 175.32% |
| Dec 29, 2023 | 12.18M | 74.85% |
| Dec 30, 2022 | 6.97M | -52.05% |
| Dec 31, 2021 | 14.52M | -25.85% |
| Dec 22, 2021 | 19.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |